Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

Saved in:
Bibliographic Details
Main Authors: Kubasch, Anne Sophie (Author) , Peterlin, P. (Author) , Cluzeau, T. (Author) , Götze, K. S. (Author) , Sockel, K. (Author) , Teipel, R. (Author) , Jentzsch, M. (Author) , Attalah, H. (Author) , Sebert, M. (Author) , Chermat, F. (Author) , Gloaguen, S. (Author) , Puttrich, M. (Author) , Cross, M. (Author) , Schneider, M. (Author) , Kayser, Sabine (Author) , Schipp, D. (Author) , Giagounidis, A. (Author) , Tirado-Gonzalez, I. (Author) , Descot, A. (Author) , van de Loosdrecht, A. (Author) , Weigert, A. (Author) , Metzeler, K. H. (Author) , Fenaux, P. (Author) , Medyouf, H. (Author) , Platzbecker, Uwe (Author) , Ades, L. (Author)
Format: Article (Journal) Editorial
Language:English
Published: 21 September 2023
In: Leukemia
Year: 2023, Volume: 37, Issue: 11, Pages: 2309-2313
ISSN:1476-5551
DOI:10.1038/s41375-023-02029-1
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-023-02029-1
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-023-02029-1
Get full text
Author Notes:A.S. Kubasch, P. Peterlin, T. Cluzeau, K.S. Götze, K. Sockel, R. Teipel, M. Jentzsch, H. Attalah, M. Sebert, F. Chermat, S. Gloaguen, M. Puttrich, M. Cross, M. Schneider, S. Kayser, D. Schipp, A. Giagounidis, I. Tirado-Gonzalez, A. Descot, A. van de Loosdrecht, A. Weigert, K.H. Metzeler, P. Fenaux, H. Medyouf, U. Platzbecker and L. Ades
Description
Item Description:Online veröffentlicht: 21. September 2023
Gesehen am 11.12.2023
Physical Description:Online Resource
ISSN:1476-5551
DOI:10.1038/s41375-023-02029-1